Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma
- PMID: 18485616
- PMCID: PMC2953789
- DOI: 10.1016/j.ijrobp.2008.03.056
Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma
Abstract
Purpose: Acute and late changes in magnetic resonance imaging of the pediatric brain have been described after radiotherapy (RT). We report the post-RT neuroimaging changes in the posterior fossa after intensity-modulated RT (IMRT) in children with medulloblastoma and contrast them with those of leptomeningeal disease.
Methods and materials: We performed a retrospective review of 53 consecutive children with medulloblastoma who were treated with craniospinal RT followed by IMRT to the posterior fossa and chemotherapy between 1997 and 2006.
Results: After IMRT to the posterior fossa, 8 (15%) of 53 patients developed increased fluid-attenuated inversion-recovery signal changes in the brainstem or cerebellum and patchy, multifocal, nodular contrast enhancement at a median of 6 months. The enhancement superficially resembled leptomeningeal disease. However, the enhancement resolved without intervention at a median of 6 months later. The accompanying fluid-attenuated inversion-recovery signal changes occasionally preceded the enhancement, were often parenchymal in location, and resolved or persisted to a lesser degree. All 8 patients with transient magnetic resonance imaging changes in the posterior fossa were alive at last follow-up. In contrast, leptomeningeal disease occurred in 8 (15%) of our 53 patients at a median of 19.5 months after IMRT completion. Of these 8 patients, 7 demonstrated initial nodular enhancement outside the conformal field, and 7 patients died.
Conclusion: Magnetic resonance imaging changes can occur in the posterior fossa of children treated with IMRT for medulloblastoma. In our experience, these transient changes occur at a characteristic time and location after RT, allowing them to be distinguished from leptomeningeal disease.
Conflict of interest statement
Conflict of interest: none.
Figures




Similar articles
-
Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):362-72. doi: 10.1016/j.ijrobp.2005.01.060. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168831
-
Correlation of Acute and Late Brainstem Toxicities With Dose-Volume Data for Pediatric Patients With Posterior Fossa Malignancies.Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):360-366. doi: 10.1016/j.ijrobp.2017.02.092. Epub 2017 Mar 19. Int J Radiat Oncol Biol Phys. 2017. PMID: 28463155
-
Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):143-6. doi: 10.1016/s0360-3016(98)00178-3. Int J Radiat Oncol Biol Phys. 1998. PMID: 9747831
-
The influence of pretreatment characteristics and radiotherapy parameters on time interval to development of radiation-associated meningioma.Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1408-14. doi: 10.1016/j.ijrobp.2009.01.052. Epub 2009 Apr 23. Int J Radiat Oncol Biol Phys. 2009. PMID: 19394163 Review.
-
Radiation-induced meningioma in children: report of two cases and review of the literature.Pediatr Radiol. 1996;26(8):537-41. doi: 10.1007/BF01372237. Pediatr Radiol. 1996. PMID: 8753667 Review.
Cited by
-
Pretreatment Normal WM Magnetization Transfer Ratio Predicts Risk of Radiation Necrosis in Patients with Medulloblastoma.AJNR Am J Neuroradiol. 2022 Feb;43(2):299-303. doi: 10.3174/ajnr.A7393. Epub 2022 Jan 20. AJNR Am J Neuroradiol. 2022. PMID: 35058296 Free PMC article.
-
Imaging changes in very young children with brain tumors treated with proton therapy and chemotherapy.AJNR Am J Neuroradiol. 2013 Feb;34(2):446-50. doi: 10.3174/ajnr.A3219. Epub 2012 Jul 19. AJNR Am J Neuroradiol. 2013. PMID: 22821924 Free PMC article.
-
Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational study.Strahlenther Onkol. 2013 Sep;189(9):759-64. doi: 10.1007/s00066-013-0408-0. Epub 2013 Aug 22. Strahlenther Onkol. 2013. PMID: 23963155
-
The role of radiotherapy in adult medulloblastoma: long-term single-institution experience and a review of the literature.J Neurooncol. 2012 Jan;106(2):315-23. doi: 10.1007/s11060-011-0665-7. Epub 2011 Jul 31. J Neurooncol. 2012. PMID: 21805324 Review.
-
Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?Neuroradiology. 2019 Jul;61(7):775-782. doi: 10.1007/s00234-019-02215-y. Epub 2019 Apr 18. Neuroradiology. 2019. PMID: 31001647
References
-
- Blaney SM, Kun LE, Hunter J, et al. Tumors of the central nervous system. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 5. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. pp. 818–825.
-
- Teh BS, Woo SY, Butler EB. Intensity modulated radiation therapy (IMRT): A new promising technology in radiation oncology. Oncologist. 1999;4:433–442. - PubMed
-
- Hertzberg H, Huk WJ, Ueberall MA, et al. for the German Late Effects Working Group. CNS late effects after ALL therapy in childhood: Part I. Neurological findings in long-term survivors of childhood ALL—An evaluation of the interferences between morphology and neuropsychological performance. Med Pediatr Oncol. 1997;28:387–400. - PubMed
-
- Bakardjiev AI, Barnes PD, Goumnerova LC, et al. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer. 1996;78:864–873. - PubMed
-
- Helton KJ, Edwards M, Steen G, et al. Neuroimaging-detected late transient treatment-induced lesions in pediatric patients with brain tumors. J Neurosurg. 2005;102(Suppl 2):179–186. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical